343 related articles for article (PubMed ID: 27520860)
1. Optimal Management of the Axilla: A Look at the Evidence.
Mamounas ET
Adv Surg; 2016 Sep; 50(1):29-40. PubMed ID: 27520860
[No Abstract] [Full Text] [Related]
2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
3. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
4. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
5. Management of axillary disease.
Caudle AS; Cupp JA; Kuerer HM
Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
[TBL] [Abstract][Full Text] [Related]
6. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
7. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
8. Overexploring and overtreating the axilla.
Galimberti V; Corso G; Monti S; Pagani G
Breast; 2017 Feb; 31():290-294. PubMed ID: 27282983
[No Abstract] [Full Text] [Related]
9. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
[TBL] [Abstract][Full Text] [Related]
10. [Positive sentinel node in breast cancer - when and why also opt for axillary dissection?].
Krsička P; Coufal O; Zapletal O
Rozhl Chir; 2013 Dec; 92(12):684-9. PubMed ID: 24479511
[TBL] [Abstract][Full Text] [Related]
11. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
[TBL] [Abstract][Full Text] [Related]
12. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials.
Robertson JF; Herrod PJ; Matthew J; Kilburn LS; Coles CE; Bradbury I
Crit Rev Oncol Hematol; 2017 Feb; 110():74-80. PubMed ID: 28109407
[TBL] [Abstract][Full Text] [Related]
14. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
[TBL] [Abstract][Full Text] [Related]
15. The evolution of lymph node assessment in breast cancer.
Quan ML; McCready D
J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
[TBL] [Abstract][Full Text] [Related]
16. Management of the clinically node-negative axilla: what have we learned from the clinical trials?
Pilewskie ML; Morrow M
Oncology (Williston Park); 2014 May; 28(5):371-8. PubMed ID: 25004648
[TBL] [Abstract][Full Text] [Related]
17. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy.
Moonka R; Hunter JA; Cray WK; Duncan M; Wechter DG
Am J Surg; 2002 May; 183(5):558-61. PubMed ID: 12034393
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
19. Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer.
Ponzone R; Ruatta F; Gatti M; Castellano I; Geuna E; Amato G; Kubatzki F; Sgandurra P; Sapino A; Montemurro F
Cancer Treat Rev; 2016 Jul; 48():1-7. PubMed ID: 27262016
[TBL] [Abstract][Full Text] [Related]
20. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
Recht A
Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
